Crossref journal-article
Elsevier BV
Journal of Allergy and Clinical Immunology (78)
Bibliography

Engler, R. J. M., Kenner, J., & Leung, D. Y. M. (2002). Smallpox vaccination: Risk considerations for patients with atopic dermatitis. Journal of Allergy and Clinical Immunology, 110(3), 357–365.

Authors 3
  1. Renata J.M. Engler (first)
  2. Julie Kenner (additional)
  3. Donald Y.M. Leung (additional)
References 73 Referenced 112
  1. 10.1067/mai.2002.121947 / J Allergy Clin Immunol / Bioterrorism: relevance to allergy and immunology in clinical practice by Fritz (2002)
  2. 10.1056/NEJM200204253461702 / N Engl J Med / Smallpox and bioterrorism by Drazen (2002)
  3. 10.1056/NEJMra020025 / N Engl J Med / Diagnosis and management of smallpox by Breman (2002)
  4. 10.1056/NEJM200204253461713 / N Engl J Med / The case for voluntary smallpox vaccination by Bicknell (2002)
  5. 10.1126/science.294.5544.985 / Science / Bioterrorism. Smallpox vaccinations: how much protection remains? by Cohen (2001)
  6. 10.1056/NEJM200102013440511 / N Engl J Med / The last smallpox epidemic in Boston and the vaccination controversy, 1901-1903 by Albert (2001)
  7. {'key': '10.1067/mai.2002.128052_bib7', 'first-page': '1319', 'article-title': 'Smallpox vaccination policy—the need for dialogue', 'volume': '346', 'author': 'Fauci', 'year': '2002', 'journal-title': 'N Engl J Med'} / N Engl J Med / Smallpox vaccination policy—the need for dialogue by Fauci (2002)
  8. {'key': '10.1067/mai.2002.128052_bib8', 'first-page': '74', 'article-title': 'Smallpox and vaccinia', 'author': 'Henderson', 'year': '1999'} / Smallpox and vaccinia by Henderson (1999)
  9. 10.1542/peds.26.2.176 / Pediatrics / Studies on smallpox and complications of smallpox vaccination by Kempe (1960)
  10. {'key': '10.1067/mai.2002.128052_bib10', 'first-page': '122', 'article-title': 'Smallpox and its eradication', 'author': 'Fenner', 'year': '1988'} / Smallpox and its eradication by Fenner (1988)
  11. 10.1093/infdis/122.4.303 / J Infect Dis / Complications of smallpox vaccination, 1968: results of ten statewide surveys by Lane (1970)
  12. 10.1056/NEJM196911272812201 / N Engl J Med / Complications of smallpox vaccination, 1968 by Lane (1969)
  13. 10.1146/annurev.me.22.020171.001343 / Annu Rev Med / Smallpox and smallpox vaccination policy by Lane (1971)
  14. {'key': '10.1067/mai.2002.128052_bib14', 'first-page': '1', 'volume': '50', 'author': 'Vaccinia (smallpox vaccine) recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001. (RR-10)', 'year': '2001', 'journal-title': 'MMWR'} / MMWR by Vaccinia (smallpox vaccine) recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001. (RR-10) (2001)
  15. 10.1093/milmed/165.4.287 / Mil Med / Adverse reactions to smallpox vaccine: the Israel Defense Force Experience, 1991-1996. A comparison with previous surveys by Haim (2000)
  16. {'key': '10.1067/mai.2002.128052_bib16', 'first-page': '401', 'article-title': 'Human poxvirus diseases', 'author': 'Nakano', 'year': '1985'} / Human poxvirus diseases by Nakano (1985)
  17. 10.1016/S0966-842X(00)01830-8 / Trends Microbiol / Viral mechanisms of immune evasion by Alcami (2000)
  18. 10.1073/pnas.160027697 / Proc Natl Acad Sci U S A / A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling by Bowie (2000)
  19. {'key': '10.1067/mai.2002.128052_bib19', 'first-page': '4', 'article-title': 'Pathology of the skin with clinical correlations', 'author': 'McKee', 'year': '1996'} / Pathology of the skin with clinical correlations by McKee (1996)
  20. {'key': '10.1067/mai.2002.128052_bib20', 'series-title': 'Textbook of dermatopathology', 'author': 'Barnhill', 'year': '1998'} / Textbook of dermatopathology by Barnhill (1998)
  21. {'key': '10.1067/mai.2002.128052_bib21', 'first-page': '149', 'article-title': 'Observations on the formation of smallpox scars', 'volume': '54', 'author': 'Bras', 'year': '1952', 'journal-title': 'Arch Pathol'} / Arch Pathol / Observations on the formation of smallpox scars by Bras (1952)
  22. 10.1136/bmj.2.5414.906 / Br Med J / Eczema vaccinatum by Copeman (1964)
  23. 10.1093/oxfordjournals.aje.a121252 / Am J Epidemiol / Risks of smallpox vaccination complications in the United States by Lane (1971)
  24. 10.1001/archderm.1935.01470030093010 / Arch Dermatol / Evolution of atopic dermatitis by Hill (1935)
  25. 10.2340/00015555924447 / Acta Dermatol Venereol (Stockh) / Diagnostic features of atopic dermatitis by Hanifin (1980)
  26. 10.1016/S0889-8561(03)00066-3 / Immunol Allergy Clin North Am / Epidemiology of atopic dermatitis by Schultz Larsen (2002)
  27. 10.1111/j.1365-2133.1956.tb12805.x / Br J Dermatol / Incidence of eczema in early childhood by Walker (1956)
  28. 10.1016/S0140-6736(84)92805-8 / Lancet / Changes in the reported prevalence of childhood eczema since the 1939-45 war by Taylor (1984)
  29. 10.1067/mjd.2000.107773 / J Am Acad Dermatol / The prevalence of atopic dermatitis in Oregon schoolchildren by Laughter (2000)
  30. 10.1080/000155598441891 / Acta Derm Venereol / Prevalence of childhood and adolescent atopic dermatitis in a Japanese population: comparison with the disease frequency examined 20 years ago by Sugiura (1998)
  31. 10.1542/peds.26.2.176 / Pediatrics / Studies on smallpox and complications of smallpox vaccination by Kempe (1968)
  32. 10.1017/S0022172400037979 / J Hyg / The antibody response in man following infection with viruses of the pox group. II. Antibody response following vaccination by McCarthy (1958)
  33. 10.1017/S0022172400042066 / J Hyg (Lond) / Antibody response in non-haemorrhagic smallpox patients by Downie (1969)
  34. 10.1017/S0022172400037980 / J Hyg / The antibody response in man following infection with viruses of the pox group. III. Antibody response in smallpox by Downie (1958)
  35. 10.1017/S0022172400042078 / J Hyg (Lond) / Haemorrhagic smallpox by Downie (1969)
  36. 10.4269/ajtmh.1977.26.517 / Am J Trop Med Hyg / T and B rosetting lymphocytes in the blood of smallpox patients by Jackson (1977)
  37. {'key': '10.1067/mai.2002.128052_bib37', 'first-page': '56', 'article-title': 'T cell response to viral and bacterial infection', 'volume': '19', 'author': 'Blanden', 'year': '1974', 'journal-title': 'Transplant Rev'} / Transplant Rev / T cell response to viral and bacterial infection by Blanden (1974)
  38. {'key': '10.1067/mai.2002.128052_bib38', 'first-page': '1', 'article-title': 'Immunology of poxviruses', 'author': 'Cole', 'year': '1982'} / Immunology of poxviruses by Cole (1982)
  39. 10.4049/jimmunol.146.12.4301 / J Immunol / Antiviral protection by CD8+ versus CD4+ T cells. CD8+ T cells correlating with cytotoxic activity in vitro are more efficient in antivaccinia virus protection than CD4-dependent IL by Binder (1991)
  40. 10.1086/340517 / J Infect Dis / Primary induction of human CD8+ cytotoxic T lymphocytes and interferon-gamma-producing T cells after smallpox vaccination by Ennis (2002)
  41. 10.1126/science.7690156 / Science / Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase by Karupiah (1993)
  42. 10.1034/j.1600-065X.2000.17720.x / Immunol Rev / Interferon-inducible chemokines and immunity to poxvirus infections by Mahalingam (2000)
  43. {'key': '10.1067/mai.2002.128052_bib43', 'first-page': '353', 'article-title': 'The antiviral activity of immune CD8+ T cells is dependent on interferon-gamma', 'volume': '10', 'author': 'Ruby', 'year': '1991', 'journal-title': 'Lymphokine Cytokine Res'} / Lymphokine Cytokine Res / The antiviral activity of immune CD8+ T cells is dependent on interferon-gamma by Ruby (1991)
  44. 10.1006/cyto.1998.0453 / Cytokine / In vivo antiviral effect of interleukin 18 in a mouse model of vaccinia virus infection by Tanaka-Kataoka (1999)
  45. 10.1016/S0167-0115(01)00282-8 / Regul Pept / Human alpha-defensin 1 (HNP-1) inhibits ade-noviral infection in vitro by Bastian (2001)
  46. 10.1016/S0952-7915(00)00241-7 / Curr Opin Immunol / NK cells and NKT cells in innate defense against viral infections by Biron (2001)
  47. 10.4049/jimmunol.166.11.6784 / J Immunol / Innate immunity to viruses: control of vaccinia virus infection by gamma delta T cells by Selin (2001)
  48. 10.1086/513968 / J Infect Dis / Immunologic responses to vaccinia vaccines administered by different parenteral routes by McClain (1997)
  49. 10.1093/infdis/135.1.183 / J Infect Dis / Clinical and serologic study of four smallpox vaccines comparing variations of dose and route of administration. Summary by Galasso (1977)
  50. 10.1093/infdis/161.3.446 / J Infect Dis / The persistence of neutralizing antibodies after revaccination against smallpox by el-Ad (1990)
  51. 10.1128/JVI.67.3.1538-1544.1993 / J Virol / Vaccinia virus-specific CD8+ cytotoxic T lymphocytes in humans by Demkowicz (1993)
  52. 10.1128/JVI.70.4.2627-2631.1996 / J Virol / Human cytotoxic T-cell memory: long-lived responses to vaccinia virus by Demkowicz (1996)
  53. 10.4269/ajtmh.1972.21.214 / Am J Trop Med Hyg / A prospective study of serum antibody and protection against smallpox by Mack (1972)
  54. 10.1111/j.1365-4362.1995.tb04421.x / Int J Dermatol / Revisit to Kaposi's varicelliform eruption: role of IL-4 by Raychaudhuri (1995)
  55. 10.1128/JVI.75.3.1205-1210.2001 / J Virol / Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resist-ance to mousepox by Jackson (2001)
  56. 10.1128/JVI.70.10.7103-7107.1996 / J Virol / Interleukin-4 mediates down regulation of antiviral cytokine expression and cytotoxic T-lymphocyte responses and exacerbates vaccinia virus infection in vivo by Sharma (1996)
  57. 10.1067/mai.2000.106484 / J Allergy Clin Immunol / Atopic dermatitis: new insights and opportunities for therapeutic intervention by Leung (2000)
  58. 10.1016/S0091-6749(96)70246-4 / J Allergy Clin Immunol / In vivo expression of IL-12 and IL-13 in atopic dermatitis by Hamid (1996)
  59. 10.1172/JCI117408 / J Clin Invest / Differential cytokine gene expression in acute vs chronic atopic dermatitis by Hamid (1994)
  60. 10.1067/mai.2001.118601 / J Allergy Clin Immunol / Expression of IL-18 mRNA and secretion of IL-18 are reduced in monocytes from patients with atopic dermatitis by Higashi (2001)
  61. 10.4049/jimmunol.130.4.1678 / J Immunol / Cellular basis of defective cell-mediated lympholysis in atopic dermatitis by Leung (1983)
  62. 10.1016/S0091-6749(98)70092-2 / J Allergy Clin Immunol / Unique profile of IL-4 and IFN-gamma production by peripheral blood mononuclear cells in infants with atopic dermatitis by Kimura (1998)
  63. 10.1046/j.1365-2249.1999.00814.x / Clin Exp Immunol / Intracellular interferon-gamma (IFN-gamma) production in normal children and children with atopic dermatitis by Campbell (1999)
  64. 10.1111/j.1365-2222.1985.tb02298.x / Clin Allergy / Natural killer cell activity in atopic dermatitis: a sequential study by Lever (1985)
  65. 10.1067/mai.2001.114240 / J Allergy Clin Immunol / Perforin hyperreleasability and depletion in cytotoxic T cells from patients with exacerbated atopic dermatitis and asymptomatic rhinoconjunctivitis allergica by Ambach (2001)
  66. 10.1002/eji.1830251209 / Eur J Immunol / The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses by Kagi (1995)
  67. 10.1067/mai.2001.114707 / J Allergy Clin Immunol / Kertinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines by Giustizieri (2001)
  68. {'issue': '1 pt 2', 'key': '10.1067/mai.2002.128052_bib68', 'first-page': '779A', 'article-title': 'Reduced expression of human β defensin-2 (HBD-2) and CCR6 in atopic dermatitis (AD)', 'volume': '109', 'author': 'Ong', 'year': '2002', 'journal-title': 'J Allergy Clin Immunol'} / J Allergy Clin Immunol / Reduced expression of human β defensin-2 (HBD-2) and CCR6 in atopic dermatitis (AD) by Ong (2002)
  69. 10.1067/mai.2001.117457 / J Allergy Clin Immunol / Antigen-presenting cells in allergy by von Bubnoff (2001)
  70. 10.1016/S0091-6749(00)90190-8 / J Allergy Clin Immunol / IL-4 induces the intracellular expression of the alpha chain of the high-affinity receptor for IgE in in vitro-generated dendritic cells by Geiger (2000)
  71. 10.1067/mai.2001.117259 / J Allergy Clin Immunol / Atopic dermatitis is associated with a low-producer transforming growth factor β1 cytokine genotype by Arkwright (2001)
  72. 10.4049/jimmunol.154.4.1956 / J Immunol / Overexpression of IL-10 in atopic dermatitis. Contrasting cytokine patterns with delayed-type hypersensitivity reactions by Ohmen (1995)
  73. 10.1016/S0264-410X(01)00171-2 / Vaccine / MVA: a cuckoo in the vaccine nest? by Stittelaar (2001)
Dates
Type When
Created 22 years, 10 months ago (Oct. 9, 2002, 5:24 p.m.)
Deposited 2 years, 4 months ago (April 24, 2023, 2:16 p.m.)
Indexed 4 months, 2 weeks ago (April 10, 2025, 7:47 a.m.)
Issued 22 years, 11 months ago (Sept. 1, 2002)
Published 22 years, 11 months ago (Sept. 1, 2002)
Published Print 22 years, 11 months ago (Sept. 1, 2002)
Funders 0

None

@article{Engler_2002, title={Smallpox vaccination: Risk considerations for patients with atopic dermatitis}, volume={110}, ISSN={0091-6749}, url={http://dx.doi.org/10.1067/mai.2002.128052}, DOI={10.1067/mai.2002.128052}, number={3}, journal={Journal of Allergy and Clinical Immunology}, publisher={Elsevier BV}, author={Engler, Renata J.M. and Kenner, Julie and Leung, Donald Y.M.}, year={2002}, month=sep, pages={357–365} }